Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.480
+0.100 (2.96%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Perspective Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$12.90
Upside
+270.69%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +244.83% | Jun 23, 2025 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +216.09% | Jun 23, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +359.77% | Jun 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +129.89% | May 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +187.36% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +187.36% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +331.03% | Mar 27, 2025 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +216.09% | Mar 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +187.36% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +187.36% | Mar 13, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $15 | Buy | Initiates | $15 | +331.03% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +359.77% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $16 | Buy | Maintains | $25 → $16 | +359.77% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $24 → $6 | Strong Buy → Hold | Downgrades | $24 → $6 | +72.41% | Nov 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +359.77% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +474.71% | Oct 24, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.